Join the Tadalafil group to help and get support from people like you.
Tadalafil News
Viagra, Cialis Plus a Heart Med Could Be a Dangerous Combo
MONDAY, Jan. 15, 2024 – Taking nitrates for heart problems alongside erectile dysfunction drugs like Viagra or Cialis could be a prescription for trouble, a new study warns. Men who combine the two...
Erectile Troubles in Middle Age a Bad Sign for Men's Brains
FRIDAY, June 2, 2023 – Erectile dysfunction (ED) has been tied to an increased risk of diabetes, high blood pressure and heart disease. Now, research suggests that erectile woes during late middle...
FDA Medwatch Alert: Proper Trade LLC/My Stellar Lifestyle Issues Voluntary Nationwide Recall of Wonder Pill Capsules Due to the Presence of Undeclared Tadalafil
September 28, 2022 – Proper Trade LLC/My Stellar Lifestyle is voluntarily recalling Wonder Pill lot 20210912 and lot 31853-501, expiry 09/24, packaged in 10-count blisters co-packaged in a carton...
FDA Medwatch Alert: MKS Enterprise LLC Voluntary Recalls of Dose Vital VIP Vital Honey Due to Presence of Undeclared Tadalafil
July 19, 2022 – This product was found to contain the undeclared active pharmaceutical ingredient tadalafil. Tadalafil, which is a phosphodiesterase type-5 (PDE-5) inhibitor, is the active...
FDA Approves Entadfi (finasteride and tadalafil) as a New Treatment for Benign Prostatic Hyperplasia
MIAMI, Dec. 13, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, a...
FDA Medwatch Alert: Dietary Supplements for Male Sexual Enhancement by A and H Focal: Recall - Undeclared Drug Ingredient
[Posted 03/07/2017] ISSUE: A&H Focal Inc. is voluntarily recalling all lots marketed as dietary supplements for male sexual enhancement from January 2014 to present. These products have been...
FDA Medwatch Alert: SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient
ISSUE: BeaMonstar Products notified the public that it is recalling its SexVoltz, Velextra, and Amerect capsules to the retail level. Laboratory analysis conducted by the FDA on SexVoltz and Velextra...
FDA Medwatch Alert: Bullet Proof: Public Notification - Undeclared Drug Ingredient
ISSUE: FDA is advising consumers not to purchase or use “Bullet Proof,” a product promoted and sold for sexual enhancement on various websites and in some retail stores. FDA laboratory analysis con...
FDA Medwatch Alert: American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug Ingredient
ISSUE: May 1, 2013 - American Lifestyle is announcing that it is conducting a voluntary recall of all lots of Vicerex UPC 893490820087 and Black Ant UPC 4026666142546. Laboratory analysis conducted...
FDA Medwatch Alert: Mojo Nights and Mojo Nights for Her: Recall - Undeclared Drug Ingredient
ISSUE: Evol Nutrition Associates, Inc./Red Dawn (“Evol Nutrition”) notified the public of a nationwide recall of all lots of two dietary supplement products distributed by the company under the names ...
FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
October 6, 2011 – The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Benign Prostatic Hyperplasia (BPH), Erectile Dysfunction